College of Medicine
Zarrinpar Lab
Led by Ali Zarrinpar · Surgery
What we study
The lab studies liver diseases and cancers, focusing on surgery and transplantation. They develop technologies to improve patient care, such as using genetic analysis to predict outcomes.
What working here is like
- Clinical
- Human participants
- Papers
- 5
Recent papers, explained
- Alcohol reshapes liver zonal plasticity and immune-metabolic reprogramming in metabolic-syndrome associated hepatocellular carcinoma
2026 · Nature Communications
Shows how alcohol changes liver structure and immune responses in liver cancer.
- Understanding hepatocellular carcinoma development using longitudinal laboratory measurements
2026 · BMC Gastroenterology
Analyzes how longitudinal lab tests can better predict HCC development in chronic liver disease patients.
Show 3 more papersShow fewer
- β-Catenin Signaling in Hepatocellular Carcinoma: Mechanisms of Therapeutic Resistance and Emerging Therapeutic Strategies
2026 · Current Oncology
Explores how β-catenin signaling contributes to HCC progression and resistance to treatments.
- As Organ Supply Expands, Equity Must Be Reimagined
2026 · JAMA
- Cyclosporine treatment of ARDS due to severe COVID-19: The I-SPY COVID Adaptive Platform Trial
2026 · Annals of the American Thoracic Society
Tests whether cyclosporine can improve recovery and reduce death in severe COVID-19 patients with ARDS.
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Ali Zarrinpar hasn't set up this page yet. You can also look them up in the UF directory (search “Ali Zarrinpar”).